Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2018

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2018

Summary

The clinical trial report, Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2018" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Reflux Esophagitis (Gastroesophageal Reflux Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level


List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Reflux Esophagitis (Gastroesophageal Reflux Disease) 30
Jun 21, 2018: Ironwood begins two Phase III trials of IW-3718 30
Jun 05, 2018: Ironwood Pharmaceuticals Presents IW-3718 Data Showing Improvements in Heartburn and Regurgitation Symptoms in Patients with Persistent GERD at Digestive Disease Week 2018 30
May 23, 2018: Ironwood Pharmaceuticals to Highlight Clinical Data for IW-3718 in Persistent Gastroesophageal Reflux Disease (GERD) at Digestive Disease Week 2018 31
Apr 16, 2018: First clinical study successfully completed with X842, an innovative promising treatment for severe erosive GERD 32
Clinical Trial Profile Snapshots 33
Appendix 589
Abbreviations 589
Definitions 589
Research Methodology 590
Secondary Research 590
About GlobalData 591
Contact Us 591
Source 591

List Of Tables


Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 13
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, G7 Countries (%), 2018* 15
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, E7 Countries (%), 2018* 18
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List Of Figures


Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 13
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, G7 Countries (%), 2018* 15
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, E7 Countries (%), 2018* 18
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 590

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2018

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2018The clinical trial report, Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2018 provides an overview of Reflux

USD 2500 View Report

Reflux Esophagitis (Gastro esophageal Reflux Disease) - Pipeline Review, H2 2018

Reflux Esophagitis (Gastro esophageal Reflux Disease) - Pipeline Review, H2 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Reflux Esophagitis - Pipeline Review, H2 2018, provides an overview

USD 2000 View Report

Reflux Esophagitis (Gastro esophageal Reflux Disease) - Pipeline Review, H2 2018

Reflux Esophagitis (Gastro esophageal Reflux Disease) - Pipeline Review, H2 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Reflux Esophagitis - Pipeline Review, H2 2018, provides an overview

USD 2000 View Report

Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2018

Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2018, provides

USD 2000 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available